These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2579355)

  • 1. CSF immune complexes in multiple sclerosis.
    Coyle PK
    Neurology; 1985 Mar; 35(3):429-32. PubMed ID: 2579355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis immune complexes: an analysis of component antigens and antibodies.
    Coyle PK; Procyk-Dougherty Z
    Ann Neurol; 1984 Dec; 16(6):660-7. PubMed ID: 6098217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelin basic protein: a component of circulating immune complexes in multiple sclerosis.
    Dasgupta MK; Catz I; Warren KG; McPherson TA; Dossetor JB; Carnegie PR
    Can J Neurol Sci; 1983 Nov; 10(4):239-43. PubMed ID: 6197152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin basic protein in CSF as indicator of disease activity in multiple sclerosis.
    Lamers KJ; de Reus HP; Jongen PJ
    Mult Scler; 1998 Jun; 4(3):124-6. PubMed ID: 9762659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin basic protein and demyelinating diseases.
    Gupta MK
    Crit Rev Clin Lab Sci; 1987; 24(4):287-314. PubMed ID: 2436854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
    Kasai N; Pachner AR; Yu RK
    J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
    Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
    J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of CSF studies to diagnosis of multiple sclerosis.
    Link H
    Ital J Neurol Sci; 1987 Jun; Suppl 6():57-69. PubMed ID: 2443465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and isolation of immune complexes in multiple sclerosis cerebrospinal fluid.
    Coyle PK
    J Neuroimmunol; 1987 May; 15(1):97-107. PubMed ID: 3571487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens.
    Yao SY; Stratton CW; Mitchell WM; Sriram S
    Neurology; 2001 May; 56(9):1168-76. PubMed ID: 11342681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis.
    Sellebjerg F; Christiansen M; Garred P
    Mult Scler; 1998 Jun; 4(3):127-31. PubMed ID: 9762660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.
    Van der Aa A; Hellings N; Medaer R; Gelin G; Palmers Y; Raus J; Stinissen P
    Clin Exp Immunol; 2003 Jan; 131(1):155-68. PubMed ID: 12519400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS.
    Chou CH; Tourtellotte WW; Kibler RF
    Neurology; 1983 Jan; 33(1):24-8. PubMed ID: 6184646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune complexes in serum and cerebrospinal fluid of multiple sclerosis patients and patients with other neurological diseases.
    Salmi A; Ziola B; Reunanen M; Julkunen I; Wager O
    Acta Neurol Scand; 1982 Jul; 66(1):1-15. PubMed ID: 7113673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis.
    Cruz M; Olsson T; Ernerudh J; Höjeberg B; Link H
    Neurology; 1987 Sep; 37(9):1515-9. PubMed ID: 2442667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis.
    Zhou SR; Maier CC; Mitchell GW; LaGanke CC; Blalock JE; Whitaker JN
    Neurology; 1998 Feb; 50(2):411-7. PubMed ID: 9484364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research approaches on the diagnosis of multiple sclerosis by CSF examination.
    Schmidt RM; Kuppe G; Kissig B; Ludewig R; Neumann V
    Schweiz Arch Neurol Psychiatr (1985); 1987; 138(3):13-22. PubMed ID: 2441464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.